Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?
From single to multicellular organisms, protective mechanisms have evolved against endogenous and exogenous noxious stimuli. Preconditioning paradigms, in which stimulation below the threshold of injury results in subsequent protection of the brain, have played an important role in elucidating such endogenous protective mechanisms. Consequently, over the past decades numerous signaling pathways have been discovered by which the brain senses and reacts to such insults as neurotoxins, substrate deprivation, or inflammation. Research on preconditioning is aimed at understanding endogenous neuroprotection to boost it, or to supplement its effectors therapeutically once damage to the brain has occurred, such as after stroke or brain trauma. Another goal of establishing preconditioning protocols is to induce endogenous neuroprotection in anticipation of incipient brain damage. Currently several endogenous neuroprotectants are being investigated in controlled clinical trials. In the present review we will give a short overview on the signals, sensors, transducers, and effectors of endogenous neuroprotection. We will first focus on common mechanisms, on which pathways of endogenous neuroprotection converge, and in particular on mitochondria, which may be considered master integrators of endogenous neuroprotection. We will then discuss various applications of preconditioning, including pharmacological and anesthetic preconditioning, as well as postconditioning, and explore the prospects of endogenous neuroprotective therapeutic approaches.
Dirnagl
Ulrich
U
Department of Experimental Neurology, Center for Stroke Research Berlin, Berlin, Germany. ulrich.dirnagl@charite.de
Meisel
Andreas
A
D000818:Animals; D002545:Brain Ischemia / Q000276:immunology / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D019194:Ischemic Preconditioning; D008928:Mitochondria / Q000276:immunology / Q000502:physiology*